HomeC17 • FRA
add
Corvus Pharmaceuticals Inc
Previous close
€4.76
Day range
€4.97 - €4.97
Year range
€1.22 - €9.00
Market cap
339.92M USD
Avg Volume
171.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.26M | 30.49% |
Net income | -40.22M | -570.28% |
Net profit margin | — | — |
Earnings per share | -0.60 | -400.00% |
EBITDA | -7.23M | -30.81% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 41.65M | 29.48% |
Total assets | 58.82M | 13.23% |
Total liabilities | 46.41M | 506.38% |
Total equity | 12.41M | — |
Shares outstanding | 64.26M | — |
Price to book | 23.80 | — |
Return on assets | -29.40% | — |
Return on capital | -56.08% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -40.22M | -570.28% |
Cash from operations | -6.32M | -16.32% |
Cash from investing | -3.89M | -122.17% |
Cash from financing | 50.00K | -85.07% |
Net change in cash | -10.16M | -181.63% |
Free cash flow | 29.38M | 932.73% |
About
Founded
2014
Headquarters
Website
Employees
28
